FDA to Minimize Abuse Potential of OTC Antidiarrheal

The Food and Drug Administration remains concerned about potential abuse of the over-the-counter antidiarrheal loperamide. The agency is working with manufacturers to create packaging that more clearly shows the dose for consumers and to limit the number of doses in one package.Intentional abuse or unintentional overdose of loperamide can lead to serious cardiac complications and possibly death.
Source: AJN - Category: Nursing Tags: Drug Watch Source Type: research